GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » PS Ratio
中文

IntelliPharmaCeutics International (IntelliPharmaCeutics International) PS Ratio : 2.14 (As of Apr. 25, 2024)


View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, IntelliPharmaCeutics International's share price is $0.06. IntelliPharmaCeutics International's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 was $0.03. Hence, IntelliPharmaCeutics International's PS Ratio for today is 2.14.

The historical rank and industry rank for IntelliPharmaCeutics International's PS Ratio or its related term are showing as below:

IPCIF' s PS Ratio Range Over the Past 10 Years
Min: 0.54   Med: 7.48   Max: 610.45
Current: 2.16

During the past 13 years, IntelliPharmaCeutics International's highest PS Ratio was 610.45. The lowest was 0.54. And the median was 7.48.

IPCIF's PS Ratio is ranked better than
83.05% of 991 companies
in the Biotechnology industry
Industry Median: 8.98 vs IPCIF: 2.16

IntelliPharmaCeutics International's Revenue per Sharefor the three months ended in Aug. 2023 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 was $0.03.

Warning Sign:

IntelliPharmaCeutics International Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of IntelliPharmaCeutics International was 825.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -75.90% per year.

During the past 13 years, IntelliPharmaCeutics International's highest 3-Year average Revenue per Share Growth Rate was 232.90% per year. The lowest was -81.20% per year. And the median was -30.05% per year.

Back to Basics: PS Ratio


IntelliPharmaCeutics International PS Ratio Historical Data

The historical data trend for IntelliPharmaCeutics International's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International PS Ratio Chart

IntelliPharmaCeutics International Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.95 0.93 2.05 - 33.33

IntelliPharmaCeutics International Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.75 33.33 5.00 2.14 2.57

Competitive Comparison of IntelliPharmaCeutics International's PS Ratio

For the Biotechnology subindustry, IntelliPharmaCeutics International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntelliPharmaCeutics International's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's PS Ratio distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's PS Ratio falls into.



IntelliPharmaCeutics International PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

IntelliPharmaCeutics International's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.06/0.028
=2.14

IntelliPharmaCeutics International's Share Price of today is $0.06.
IntelliPharmaCeutics International's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


IntelliPharmaCeutics International  (OTCPK:IPCIF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


IntelliPharmaCeutics International PS Ratio Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Headlines